Anson Funds Management’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Anson Funds Management’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-93,750	Closed	-$285K	–	60
2017 Q1	$285K	Hold	93,750	–	–	0.12%	37
2016 Q4	$213K	Buy	+93,750	New	+$84.1K	0.07%	76

Other funds holding ONTXW

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Anson Funds Management's ONTXW Position: Q2 2017 in Review

Anson Funds Management sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q2 2017, closing a stake of 93,750 shares — an estimated $285K sold.

Anson Funds Management first reported a position in ONTXW in Q4 2016 and held it in 2 quarters. The position peaked at $285K in Q1 2017. 5 funds tracked by Wall St. Rank hold ONTXW as of Q2 2017.

Anson Funds Management reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q2 2017 after selling out during the quarter.
Anson Funds Management sold 93,750 Onconova Therapeutics, Inc. Warrants shares in Q2 2017, an estimated $285K.
Anson Funds Management first reported a position in Onconova Therapeutics, Inc. Warrants in Q4 2016 and held it in 2 quarters.
Anson Funds Management's Onconova Therapeutics, Inc. Warrants position peaked at $285K in Q1 2017.
5 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q2 2017.

Based on Anson Funds Management's 13F filing for Q2 2017, filed 14 Aug 2017.